Liquidators of biotech startup in talks over stake in drug firm

Liquidators of biotech startup in talks over stake in drug firm
Synthase Biotech's trademarked enzyme Aloxsyn had been shown to improve the ability of cows to conceive. (Image: Unsplash)
Riley Kennedy
Liquidators of a collapsed animal-breeding startup are in talks about its stake in another drug development company.Set up in 2015, Synthase Biotech had developed a plant-based enzyme that stopped fats from going rancid.The Waikato-based company, which leased premises at AgResearch’s Ruakura campus in Hamilton, initially targeted artificial insemination for the global dairy industry and undertook its first capital raise of $800,000 in 2016.However, it collapsed in June last year after failing to find enough commercial contracts for its pr...

More Primary Sector

A new dawn awaits Alliance Group
Primary Sector Analysis

A new dawn awaits Alliance Group

Is the sun setting on NZ’s last fully farmer owned meat co-op?

Norwood’s losses mount as revenue slumps further
Primary Sector

Norwood’s losses mount as revenue slumps further

It’s retained “material uncertainty" on its books.

Riley Kennedy 06 Aug 2025